{"fetched":"2026-10-22","congress":{"id":"asnc","label":"ASNC Annual Scientific Session","year":2026,"journal":"Journal of Nuclear Cardiology","window":{"from":"2026-08-01","to":"2026-10-15"},"source":"https://api.crossref.org/"},"total":164,"considered":164,"matched":66,"items":[{"doi":"10.1016/j.nuclcard.2026.103001","url":"https://doi.org/10.1016/j.nuclcard.2026.103001","title":"Absolute Myocardial Blood Flow via Single-Time-Point Imaging in PET and SPECT: Cross-Validation Against Dynamic 13N-Ammonia PET","date":"2026-10-01","lba":false,"refs":{"drugs":["n-13-ammonia"],"trials":[],"targets":[],"indications":[],"technologies":["spect","spect-ct","quantitative-spect","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102932","url":"https://doi.org/10.1016/j.nuclcard.2026.102932","title":"Approaching the Next Step in Assessing Inflammation in Atherosclerosis - Rationale and Trial Design of the International Multicenter PIAF Trial (PrognostIc Value of Arterial 18F-FDG PET Imaging in Patients with History of Myocardial Inflammation)","date":"2026-09-01","lba":false,"refs":{"drugs":["f-18-fdg-brain"],"trials":[],"targets":[],"indications":[],"technologies":["fdg-pet"]}},{"doi":"10.1016/j.nuclcard.2026.102927","url":"https://doi.org/10.1016/j.nuclcard.2026.102927","title":"Assessment of Myocardial Viability Using a Novel Fatty Acid Metabolism PET Tracer (XTR003) Integrated with 18F-FDG in Patients with Ischemic Cardiomyopathy: Rationale of A Prospective Multicenter Phase IIb Study","date":"2026-09-01","lba":false,"refs":{"drugs":["f-18-fdg-brain"],"trials":[],"targets":[],"indications":[],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102914","url":"https://doi.org/10.1016/j.nuclcard.2026.102914","title":"Deep Learning-Based Detection of Coronary Artery Disease from Rest-Stress 82Rb PET Myocardial Blood Flow Parametric Maps","date":"2026-09-01","lba":false,"refs":{"drugs":["rb-82-chloride"],"trials":[],"targets":[],"indications":["coronary-artery-disease"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102907","url":"https://doi.org/10.1016/j.nuclcard.2026.102907","title":"Development and Validation of a Normal Database for Quantification of Perfusion Defects on AI-enabled 3D Parametric Mapping of Myocardial Blood Flow for 82Rb","date":"2026-09-01","lba":false,"refs":{"drugs":["rb-82-chloride"],"trials":[],"targets":[],"indications":[],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102849","url":"https://doi.org/10.1016/j.nuclcard.2026.102849","title":"Evaluation of Data-Driven Respiratory Motion Correction for Routine Use in Rb-82 Cardiac PET/CT Imaging","date":"2026-09-01","lba":false,"refs":{"drugs":["rb-82-chloride"],"trials":[],"targets":[],"indications":[],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102848","url":"https://doi.org/10.1016/j.nuclcard.2026.102848","title":"Impact of Blood Flow Reserve on Quantitative Splenic Uptake of Rb-82","date":"2026-09-01","lba":false,"refs":{"drugs":["rb-82-chloride"],"trials":[],"targets":[],"indications":[],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102904","url":"https://doi.org/10.1016/j.nuclcard.2026.102904","title":"Impact of Patient Motion on Rb-82 PET Blood Flow Quantitation Using a Rapid Net Retention Model","date":"2026-09-01","lba":false,"refs":{"drugs":["rb-82-chloride"],"trials":[],"targets":[],"indications":[],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102978","url":"https://doi.org/10.1016/j.nuclcard.2026.102978","title":"Lateral wall heterogeneity in 13N-ammonia positron emission tomography scans in heart transplant patients","date":"2026-10-01","lba":false,"refs":{"drugs":["n-13-ammonia"],"trials":[],"targets":[],"indications":[],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102930","url":"https://doi.org/10.1016/j.nuclcard.2026.102930","title":"Left ventricular volumes and ejection fraction as assessed by low-dose [82Rb] SiPM PET/CT using Transthoracic Echocardiography as reference: A Retrospective Study","date":"2026-09-01","lba":false,"refs":{"drugs":["rb-82-chloride"],"trials":[],"targets":[],"indications":[],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102908","url":"https://doi.org/10.1016/j.nuclcard.2026.102908","title":"Molecular Phenotyping With 18F-FDG and 18F-FAPI PET/CT: Advancing Risk Stratification In In-Stent Restenosis","date":"2026-09-01","lba":false,"refs":{"drugs":["f-18-fdg-brain"],"trials":[],"targets":[],"indications":[],"technologies":["fapi-pet"]}},{"doi":"10.1016/j.nuclcard.2026.102797","url":"https://doi.org/10.1016/j.nuclcard.2026.102797","title":"Normal values for 13N-ammonia PET-derived metrics in heart transplant patients","date":"2026-08-01","lba":false,"refs":{"drugs":["n-13-ammonia"],"trials":[],"targets":[],"indications":[],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102937","url":"https://doi.org/10.1016/j.nuclcard.2026.102937","title":"Role of 18F-FDG PET/CT in Diagnosis, Detection of Septic Emboli, and Treatment Response in Infective Endocarditis: Our Experience","date":"2026-09-01","lba":false,"refs":{"drugs":["f-18-fdg-brain"],"trials":[],"targets":[],"indications":[],"technologies":["fdg-pet"]}},{"doi":"10.1016/j.nuclcard.2026.102876","url":"https://doi.org/10.1016/j.nuclcard.2026.102876","title":"SPECT MIBI Utility And An Incidental Finding during Lung Cancer Screening And Its Correlation With Cardiac CT in A Rural Regional Setting To Assess Indirectly Coronary Artery Anatomy And Its Managemenet : A Different Clinical Approach","date":"2026-09-01","lba":false,"refs":{"drugs":["tc-99m-sestamibi"],"trials":[],"targets":[],"indications":["nsclc"],"technologies":["spect","spect-ct","quantitative-spect","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102823","url":"https://doi.org/10.1016/j.nuclcard.2026.102823","title":"Transient ischemic dilation in the 18F-Flurpiridaz positron emission tomography myocardial perfusion imaging era: Time to adopt radiotracer and stressor specific thresholds","date":"2026-08-01","lba":false,"refs":{"drugs":["f-18-flurpiridaz"],"trials":[],"targets":[],"indications":["pulmonary-embolism-vq"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102806","url":"https://doi.org/10.1016/j.nuclcard.2026.102806","title":"Transient ischemic dilation with 18F-flurpiridaz positron emission tomography: Establishing thresholds for a novel radiotracer","date":"2026-08-01","lba":false,"refs":{"drugs":["f-18-flurpiridaz"],"trials":[],"targets":[],"indications":[],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102970","url":"https://doi.org/10.1016/j.nuclcard.2026.102970","title":"2026 American Society of Nuclear Cardiology guideline for stress testing in single-photon emission computed tomography and positron emission tomography myocardial perfusion imaging","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["pulmonary-embolism-vq"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102851","url":"https://doi.org/10.1016/j.nuclcard.2026.102851","title":"7-Minute Acquisition Protocol for [18F] Flurpiridaz PET Myocardial Perfusion Imaging: A Feasible Alternative to the Standard Protocol","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["pulmonary-embolism-vq"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102857","url":"https://doi.org/10.1016/j.nuclcard.2026.102857","title":"A Phase 3 Open Label Multicenter Study of I124 Evuzamitide as an Imaging Agent for the Diagnosis of Cardiac Amyloidosis Using Positron Emission Tomography Computed Tomography PETCT","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["cardiac-amyloidosis-attr"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102886","url":"https://doi.org/10.1016/j.nuclcard.2026.102886","title":"A Quantitative Analysis of Florbetaben F18 Positron Emission Tomography to Assess Diagnostic Performance in Patients with Cardiac Amyloidosis","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["cardiac-amyloidosis-attr"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102865","url":"https://doi.org/10.1016/j.nuclcard.2026.102865","title":"Beyond Perugini: Uncovering Prognostic Signals in the [99mTc]Tc-DPD-Positive Spectrum of Wild Type Cardiac Amyloidosis","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["cardiac-amyloidosis-attr"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102892","url":"https://doi.org/10.1016/j.nuclcard.2026.102892","title":"Clinical Significance of Discordant Stress ECG and PET Myocardial Perfusion Imaging","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["pulmonary-embolism-vq"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102922","url":"https://doi.org/10.1016/j.nuclcard.2026.102922","title":"Clinical Utility of Deep Learning Body Composition for Patients Undergoing SPECT/CT Technetium Pyrophosphate for Cardiac Amyloidosis","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["cardiac-amyloidosis-attr"],"technologies":["spect","spect-ct","quantitative-spect","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102909","url":"https://doi.org/10.1016/j.nuclcard.2026.102909","title":"Comparative Diagnostic Accuracy of 124I-evuzamitide PET/MRI Using 30-Minute Cardiac vs 5-Minute Chest Acquisitions for Diagnosing Cardiac Amyloidosis","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["cardiac-amyloidosis-attr"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102837","url":"https://doi.org/10.1016/j.nuclcard.2026.102837","title":"Comparison of HDP versus PYP radiotracer for Cardiac Transthyretin Amyloidosis SPECT/CT study","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":[],"technologies":["spect","spect-ct","quantitative-spect","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102920","url":"https://doi.org/10.1016/j.nuclcard.2026.102920","title":"Comparison of Quantitative Positron Emission Tomography Metrics in Cardiac Amyloidosis","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["cardiac-amyloidosis-attr"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102923","url":"https://doi.org/10.1016/j.nuclcard.2026.102923","title":"Coronary Calcium on CT Attenuation Slices in Patients with Pharmacologic Stress SPECT","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":[],"technologies":["spect","spect-ct","quantitative-spect","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102864","url":"https://doi.org/10.1016/j.nuclcard.2026.102864","title":"Correlation Between Quantitative SPECT/CT Metrics and Baseline Clinical Risk Stratification Scores","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":[],"technologies":["quantitative-spect","spect","spect-ct","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102835","url":"https://doi.org/10.1016/j.nuclcard.2026.102835","title":"Diagnostic Performance of Artificial Intelligence for Cardiac Amyloidosis Detection Across ECG, Echocardiography, Scintigraphy, and CMR: A Pooled Analysis","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["cardiac-amyloidosis-attr"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102900","url":"https://doi.org/10.1016/j.nuclcard.2026.102900","title":"Differences in Patients with Angina with No Obstructive Coronary Artery Disease (ANOCA) Referred for Evaluation of Coronary Microvascular Dysfunction with Non-Invasive Imaging versus Invasive Coronary Function Testing","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["coronary-artery-disease"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102929","url":"https://doi.org/10.1016/j.nuclcard.2026.102929","title":"Economics of Cardiac Nuclear Perfusion Imaging Using Federally Mandated Hospital Chargemasters","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["pulmonary-embolism-vq"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102883","url":"https://doi.org/10.1016/j.nuclcard.2026.102883","title":"Factors Affecting Peak Pixel Counts: A Study for Optimization of Image Quality in Myocardial Perfusion SPECT for High BMI Population.","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":[],"technologies":["spect","spect-ct","quantitative-spect","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102882","url":"https://doi.org/10.1016/j.nuclcard.2026.102882","title":"Feasibility of Artificial Intelligence (AI) to Enhance Early Myocardial Perfusion Images Simultaneously Acquired from Flow Dynamic SPECT","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":[],"technologies":["spect","spect-ct","quantitative-spect","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102850","url":"https://doi.org/10.1016/j.nuclcard.2026.102850","title":"Fluorine Substitution Effects on 99mTc-4BOH Performance: Preclinical Validation of 99mTc-3-F-4BOH for Quantitative SPECT MPI","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":[],"technologies":["quantitative-spect","spect","spect-ct","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102905","url":"https://doi.org/10.1016/j.nuclcard.2026.102905","title":"From Implementation to Independence: A Structured Training Model for Technologist Upskilling in F18 Flurpiridaz PET Myocardial Perfusion Imaging","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["pulmonary-embolism-vq"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102831","url":"https://doi.org/10.1016/j.nuclcard.2026.102831","title":"Gated-SPECT Uncovers Early Subclinical Left Ventricular Remodeling in Patients with Obesity","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":[],"technologies":["spect","spect-ct","quantitative-spect","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102825","url":"https://doi.org/10.1016/j.nuclcard.2026.102825","title":"Grey zone, real risk: Making full use of positron emission tomography myocardial perfusion imaging","date":"2026-08-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["pulmonary-embolism-vq"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102862","url":"https://doi.org/10.1016/j.nuclcard.2026.102862","title":"How to Improve the Diagnostic Yield of SPECT PYP Imaging Using Commercially Available Software","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":[],"technologies":["spect","spect-ct","quantitative-spect","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102936","url":"https://doi.org/10.1016/j.nuclcard.2026.102936","title":"Imaging Pathways and Temporal Trends Preceding a New Diagnosis of Cardiac Sarcoidosis in a National Cohort","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["cardiac-sarcoidosis"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102822","url":"https://doi.org/10.1016/j.nuclcard.2026.102822","title":"Incremental prognostic value of the hemodynamic gain index in patients undergoing exercise stress myocardial perfusion imaging","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["pulmonary-embolism-vq"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102839","url":"https://doi.org/10.1016/j.nuclcard.2026.102839","title":"Initial SPECT MPI Is Associated with Greater Downstream Noninvasive Cardiac Testing Than PET MPI: National Real World Evidence From Epic Cosmos","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":[],"technologies":["spect","spect-ct","quantitative-spect","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102853","url":"https://doi.org/10.1016/j.nuclcard.2026.102853","title":"Left Ventricular Ejection Fraction Reserve and Transient Ischemic Dilation During Regadenoson Stress F-18 Flurpiridaz PET Myocardial Perfusion Imaging.","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["pulmonary-embolism-vq"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102858","url":"https://doi.org/10.1016/j.nuclcard.2026.102858","title":"Multi-Signal Nuclear Imaging in Cardio-Oncology: Defining the Role of PET and SPECT in Detecting Early Therapy-Related Cardiotoxicity","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":[],"technologies":["spect","spect-ct","quantitative-spect","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102874","url":"https://doi.org/10.1016/j.nuclcard.2026.102874","title":"Multimodal Deep Learning for Detecting Multivessel Disease on Stress Myocardial Perfusion SPECT","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":[],"technologies":["spect","spect-ct","quantitative-spect","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102917","url":"https://doi.org/10.1016/j.nuclcard.2026.102917","title":"Myocardial Fibroblast Activation in ATTR Cardiomyopathy: Insights From (18)F-FAPI PET/MR Imaging","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":[],"technologies":["fapi-pet"]}},{"doi":"10.1016/j.nuclcard.2026.102903","url":"https://doi.org/10.1016/j.nuclcard.2026.102903","title":"Myocardial Perfusion Imaging Defects Secondary to Bi-Ventricular Pacing","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["pulmonary-embolism-vq"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102894","url":"https://doi.org/10.1016/j.nuclcard.2026.102894","title":"National Trends in PET Versus SPECT Myocardial Perfusion Imaging: Utilization, Demographic Variation, and Geographic Inequality Across a National EHR Network, 2018-2025","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["pulmonary-embolism-vq"],"technologies":["spect","spect-ct","quantitative-spect","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102938","url":"https://doi.org/10.1016/j.nuclcard.2026.102938","title":"Optimizing [18F]F-FDG PET/CT Interpretation in Infective Endocarditis: From Valve Subtypes and Microbiology to Systemic Inflammatory Burden","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":[],"technologies":["fdg-pet"]}},{"doi":"10.1016/j.nuclcard.2026.102846","url":"https://doi.org/10.1016/j.nuclcard.2026.102846","title":"PET Myocardial Perfusion Imaging Better Differentiates High Risk Patients With Hard Cardiovascular Outcomes Than SPECT: National Real-World Outcomes, 2015 to 2026 (EPIC COSMOS)","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["pulmonary-embolism-vq"],"technologies":["spect","spect-ct","quantitative-spect","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102915","url":"https://doi.org/10.1016/j.nuclcard.2026.102915","title":"Prognostic Value of Quantitative SPECT Metrics in Transthyretin Cardiac Amyloidosis (ATTR-CM)","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["cardiac-amyloidosis-attr"],"technologies":["quantitative-spect","spect","spect-ct","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102889","url":"https://doi.org/10.1016/j.nuclcard.2026.102889","title":"Quantification of Right Ventricular Amyloid Burden with Dynamic 18F-Florbetaben PET/CT and its Correlation with 99mTc-Pyrophosphate Scintigraphy, Echocardiography and Cardiac Magnetic Resonance in Patients with Non-Invasive Diagnosis of Transthyretin Cardiac Amyloidosis: A Pilot Study","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["cardiac-amyloidosis-attr"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102962","url":"https://doi.org/10.1016/j.nuclcard.2026.102962","title":"Relapse in cardiac sarcoidosis: Patterns and predictors on serial 18F-fluorodeoxyglucose positron emission tomography imaging","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["cardiac-sarcoidosis"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102910","url":"https://doi.org/10.1016/j.nuclcard.2026.102910","title":"Relationship betweenintegrated myocardial flow reserve (iMFR) andobstructive coronary artery disease and majoradversecardiac events:Findingsfrom the multi-center REFINE PET registry","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["coronary-artery-disease"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102899","url":"https://doi.org/10.1016/j.nuclcard.2026.102899","title":"Right-sided ECG in Inferior Infarction for the detection of ischemia during pharmacologic stress SPECT.","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":[],"technologies":["spect","spect-ct","quantitative-spect","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102945","url":"https://doi.org/10.1016/j.nuclcard.2026.102945","title":"Serum β-hydroxybutyrate and diagnostic interpretability of cardiac 18F-fluorodeoxyglucose positron emission tomography in suspected cardiac sarcoidosis","date":"2026-08-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["cardiac-sarcoidosis"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.103002","url":"https://doi.org/10.1016/j.nuclcard.2026.103002","title":"SGLT2 inhibitor use is associated with reduced myocardial glucose uptake during oncologic FDG PET/CT","date":"2026-10-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":[],"technologies":["fdg-pet"]}},{"doi":"10.1016/j.nuclcard.2026.102639","url":"https://doi.org/10.1016/j.nuclcard.2026.102639","title":"Significant vasodilator-induced hypotension: A mimic of vasodilator non-responsiveness in positron emission tomography/computed tomography myocardial perfusion imaging","date":"2026-08-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["pulmonary-embolism-vq"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102925","url":"https://doi.org/10.1016/j.nuclcard.2026.102925","title":"Simplified FDG PET Myocardial Viability Preparation Protocol Reduces Hypoglycemia and Improves Workflow Efficiency While Maintaining Image Quality","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":[],"technologies":["fdg-pet"]}},{"doi":"10.1016/j.nuclcard.2026.102924","url":"https://doi.org/10.1016/j.nuclcard.2026.102924","title":"Stress SPECT Myocardial Perfusion Imaging Versus Stress Echocardiography in Stable Chest Pain: A Secondary Analysis of the PROMISE Trial","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["pulmonary-embolism-vq"],"technologies":["spect","spect-ct","quantitative-spect","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102934","url":"https://doi.org/10.1016/j.nuclcard.2026.102934","title":"The Effect of Heparin on Myocardial Glucose Suppression During FDG PET","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":[],"technologies":["fdg-pet"]}},{"doi":"10.1016/j.nuclcard.2026.102856","url":"https://doi.org/10.1016/j.nuclcard.2026.102856","title":"The Effect of Residual Subtraction on Perfusion Defects with F-18 Flurpiridaz PET Myocardial Perfusion Imaging","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["pulmonary-embolism-vq"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102888","url":"https://doi.org/10.1016/j.nuclcard.2026.102888","title":"The Movahed sign (D-Shape Left Ventricle Seen on Gated Single Photon Emission Computed Tomography (SPECT) Imaging as an Indicator for Right Ventricular Overload) is also valid in Magnetic Resonance Imaging (MRI) or Computed Tomography (CT)","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":[],"technologies":["spect","spect-ct","quantitative-spect","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102891","url":"https://doi.org/10.1016/j.nuclcard.2026.102891","title":"Transition Toward SPECT/CT as the Preferred Modality in Cardiac Amyloid Radionuclide Imaging: Real World Evidence from Epic Cosmos","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":[],"technologies":["spect","spect-ct","quantitative-spect","ai-in-nuclear-medicine"]}},{"doi":"10.1016/j.nuclcard.2026.102961","url":"https://doi.org/10.1016/j.nuclcard.2026.102961","title":"Unmasking residual risk: The incremental value of the hemodynamic gain index in exercise single-photon emission computed tomography myocardial perfusion imaging","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["pulmonary-embolism-vq"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102980","url":"https://doi.org/10.1016/j.nuclcard.2026.102980","title":"Ventricular arrhythmia location corresponds more closely with myocardial scar than active inflammation in treated cardiac sarcoidosis","date":"2026-10-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["cardiac-sarcoidosis"],"technologies":[]}},{"doi":"10.1016/j.nuclcard.2026.102963","url":"https://doi.org/10.1016/j.nuclcard.2026.102963","title":"Will inflammation return? Using serial 18F-fluorodeoxyglucose positron emission tomography/computed tomography to predict relapse in cardiac sarcoidosis","date":"2026-09-01","lba":false,"refs":{"drugs":[],"trials":[],"targets":[],"indications":["cardiac-sarcoidosis"],"technologies":[]}}],"errors":[]}